Thanks! And what junk! For women who need to check for breast cancer and shareholders alike. I wonder if imds is gonna sell itself to a company who can make it happen for their.product? Sounds like selling out would be their best and only logical move at this point.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.